Hyperthyroidism in Graves' disease Antithyroid drug treatment;Hyperthyreosetyp morbus basedow-medikamentöse therapie

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 93, Issue SUPPL. 1, 1999, Pages 41-45

  Schumm Draeger, Petra Maria ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antithyroid drug treatment; Graves' disease; Hyperthyroidism; Relapse; Remission; TSH receptor anti bodies

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN RECEPTOR ANTIBODY;

COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG INDICATION; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PRACTICE GUIDELINE; RELAPSE; REMISSION; ANIMAL; REVIEW;

ANIMALS; ANTITHYROID AGENTS; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM;

EID: 0032954758     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Allanic H, Fauchet F, Orgiazzi J., Madec A M, Genetet B, Lorcy Y, Le Guerrier A M, Delambre C, Derennes V (1990) Antithyroid drugs and Graves' disease. A prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70: 675-679
2. Cooper DS (1998) Antithyroid Drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol. Metab. Clin North Am 27(1): 225-247
3. Costagliola S, Morgenthaler N, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl St, Weglöhner W, Hollidt J, Quadbeck B, Dumont J, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH (1999) Second Generation Assay for Thyrotropin Receptor Antibodies Has Superior Diagnostic Sensitivity for Graves' Disease J Clin Endocrinol Metab 1999 im Druck
4. Edmonds CJ, Tellez M (1994) Treatment of Graves' disease by carbimazole. High dose with thyroxine compared to titra-tion dose. Eur. J. Endocrinol 131: 120-124
5. Feldt-Rasmussen U, Schleusener H, Carayon P (1994) Meta-Analysis. Evaluation of the Impact of Thyrotropin Receptor Antibodies on Long Term Remission after Medical Therapy of Graves' disease. J Clin Endocrinol Metab 78: 98-102
6. Glaser NS, Styne DM (1997) Predictors of early remission of hyperthyroidism in children. JCEM 82: 1719-1726
7. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Ara M, Nagasawa T (1991) Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324: 947-953
8. Hoermann R, Spitzweg C, Poertl S, Mann K, Heufelelder AE, Schumm-Draeger P-M (1997) Regulation of intercellular adhesion molecule-1-expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor. J Clin Endocrinol Metab 82: 2048-2055
9. Mann K, Dralle H, Gärtner R, Grußendorf M, Grüters-Kieslich A, Meng W, v.z. MühlenDrainers A. Rainers C (1997) Schilddrüse. In Rationelle Therapie in der Endokrinologie, Thieme Stuttgart, New York. 35-98
10. Mc Iver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A (1996) Lack of effect of thyroxine patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 334: 220-224
11. Meng W, Meng S, Männchen E, Hampel F, Kirsch, Dannenberg G J, Krabbe S (1991) Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease. Exp Clin Endocr 97: 257-260
12. Reinwein D, Benker G, Alexander W D, Lazarus J H and the European multicenter study group of antithyroid drug treatment (1993) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J Clin Endocrinol Metab 76: 1516-1521
13. Rittmaster RS, Abbott EC, Douglas R, Givner, M, Lehmannn L, Reddy S, Salisbury SR, Schlossberg AH, Tan MH, York SE (1998) Effekt of methimazole, with or withour L-Thyroxine, on remission rates in Graves' disease. JCEM 83: 814-818
14. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr W R Schernthaner G, Schatz H, Pickardt C F, Kotulla P (1989) Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocr 120: 689-701
15. Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K, Kumagai LF, Nagataki S (1995) Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. J Clin Endocrinol Metab 80: 1479-1480
16. Wilson JD, Forster DW (1998) William's Textbook of Endocrinology, 9th ed Saunders, Philadelphia